Celiac News for March 14, 2023
advertisement
- Cohort profile: Celiac disease genomic, environmental, microbiome and metabolome study; a prospective longitudinal birth cohort study of children at-risk for celiac disease (Full text HTML, PDF)
- Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study
- The Opinion of Polish Coeliac Patients on the Knowledge of Medical Professionals and Support Groups about Coeliac Disease-A Pilot Study (Full text HTML, PDF)
- Inhibition of Transglutaminase 2 as a Therapeutic Strategy in Celiac Disease-In Vitro Studies in Intestinal Cells and Duodenal Biopsies (Full text HTML, PDF)
- Osteoporosis and Celiac Disease: Updates and Hidden Pitfalls
- Evaluation of a Single Determination of Gluten Immunogenic Peptides in Urine from Unaware Celiac Patients to Monitor Gluten-Free Diet Adherence
- Coeliac Disease Case-Control Study: Has the Time Come to Explore beyond Patients at Risk? (Full text HTML, PDF)
- Impact of Adherence to Gluten-Free Diet in Paediatric Celiac Patients on Optical Coherence Tomography Findings: Ocular İmaging Based Study
- Study of the immune response in celiac patients with selective IgA deficiency who start a gluten-free diet
- Intervention strategies in early childhood to prevent celiac disease-a mini-review
